Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA funding/identifier line for NIH grant/contract was added to the study's identifiers, and the site revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision metadata was updated from v3.6.4 to v3.6.5, indicating a newer version of the page content. This update represents a refreshed deployment of the page without changing the study details.SummaryDifference0.0%

- Check52 days agoChange DetectedA minor site revision number was updated from v3.6.3 to v3.6.4 in the page footer. This signals a backend or UI update rather than changes to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.3 instead of v3.6.2. This change is limited to the version label and does not modify the underlying study information or user experience.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2, indicating a minor build update to the page. The content and function of the study details page remain the same.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting update to the Intervention/Treatment heading, and the site revision is updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.